Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schnittman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
AIDS Research and Human Retroviruses|April 18, 1998
Phenotypic variability of lymphocyte populations in peripheral blood and lymph nodes from HIV-infected individuals and the impact of antiretroviral therapy. DATRI 003 Study Group. Division of AIDS Treatment Research InitiativeA L Landay, J Bethel, S Schnittman
The Journal of Infectious Diseases|June 2, 1998
Human immunodeficiency virus proviral DNA from peripheral blood and lymph nodes demonstrates concordant resistance mutations to zidovudine (codon 215) and didanosine (codon 74). Division of AIDS Treatment Research Initiative 003 Study GroupD Mayers, J Bethel, M A Wainberg, et al.
Journal of Clinical Immunology|July 1, 1988
Host defense against Mycobacterium-avium complexS Schnittman, H C Lane, F G Witebsky, et al.
The Journal of Infectious Diseases|March 10, 2001
Hollow-fiber unit evaluation of a new human immunodeficiency virus type 1 protease inhibitor, BMS-232632, for determination of the linked pharmacodynamic variableG L Drusano, J A Bilello, S L Preston, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1988
Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetateT M Folks, J Justement, A Kinter, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 1995
Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissueO J Cohen, G Pantaleo, M Holodniy, et al.
AIDS (London, England)|August 16, 2001
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppressionD V Havlir, P B Gilbert, K Bennett, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremiaG Pantaleo, J F Demarest, T Schacker, et al.
The Journal of Infectious Diseases|April 1, 1996
Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodesO J Cohen, G Pantaleo, M Holodniy, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
AIDS Research and Human Retroviruses|April 18, 1998
Phenotypic variability of lymphocyte populations in peripheral blood and lymph nodes from HIV-infected individuals and the impact of antiretroviral therapy. DATRI 003 Study Group. Division of AIDS Treatment Research InitiativeA L Landay, J Bethel, S Schnittman
The Journal of Infectious Diseases|June 2, 1998
Human immunodeficiency virus proviral DNA from peripheral blood and lymph nodes demonstrates concordant resistance mutations to zidovudine (codon 215) and didanosine (codon 74). Division of AIDS Treatment Research Initiative 003 Study GroupD Mayers, J Bethel, M A Wainberg, et al.
Journal of Clinical Immunology|July 1, 1988
Host defense against Mycobacterium-avium complexS Schnittman, H C Lane, F G Witebsky, et al.
The Journal of Infectious Diseases|March 10, 2001
Hollow-fiber unit evaluation of a new human immunodeficiency virus type 1 protease inhibitor, BMS-232632, for determination of the linked pharmacodynamic variableG L Drusano, J A Bilello, S L Preston, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1988
Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetateT M Folks, J Justement, A Kinter, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 1995
Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissueO J Cohen, G Pantaleo, M Holodniy, et al.
AIDS (London, England)|August 16, 2001
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppressionD V Havlir, P B Gilbert, K Bennett, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremiaG Pantaleo, J F Demarest, T Schacker, et al.
The Journal of Infectious Diseases|April 1, 1996
Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodesO J Cohen, G Pantaleo, M Holodniy, et al.
Pageof 1